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Abstract: We describe the trend of antibiotic prescribing in out-of-hours (OOH) general practices
(GP) before and during England’s first wave of the COVID-19 pandemic. We analysed practice-level
prescribing records between January 2016 to June 2020 to report the trends for the total prescribing
volume, prescribing of broad-spectrum antibiotics and key agents included in the national Quality
Premium. We performed a time-series analysis to detect measurable changes in the prescribing vol-
ume associated with COVID-19. Before COVID-19, the total prescribing volume and the percentage
of broad-spectrum antibiotics continued to decrease in-hours (IH). The prescribing of broad-spectrum
antibiotics was higher in OOH (OOH: 10.1%, IH: 8.7%), but a consistent decrease in the trimethoprim-
to-nitrofurantoin ratio was observed OOH. The OOH antibiotic prescribing volume diverged from
the historical trend in March 2020 and started to decrease by 5088 items per month. Broad-spectrum
antibiotic prescribing started to increase in OOH and IH. In OOH, co-amoxiclav and doxycycline
peaked in March to May in 2020, which was out of sync with seasonality peaks (Winter) in previous
years. While this increase might be explained by the implementation of the national guideline to use
co-amoxiclav and doxycycline to manage pneumonia in the community during COVID-19, further
investigation is required to see whether the observed reduction in OOH antibiotic prescribing persists
and how this reduction might influence antimicrobial resistance and patient outcomes.
Keywords: out-of-hours; antibiotics; antimicrobial stewardship; COVID-19
1. Introduction
Antimicrobial Resistance (AMR), the loss of effectiveness of anti-infective (antiviral,
antifungal, antibacterial and antiparasitic) medicines, jeopardises our ability to treat in-
fections [1]. Progress against the UK 5-year action plan for AMR continues to highlight
that the inappropriate use of antimicrobials in human medicine is one of the main drivers
of AMR in the UK and internationally, with at least 20% of the antibiotics prescribed in
UK primary care being inappropriate [2]. The real figure may be much higher due to poor
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diagnostic coding in primary care [3,4]. In England, primary care settings include General
Practice (GP) and other community settings. GP practice prescribing during routine hours
accounts for about 85% of primary care antibiotic items prescribed [5]. Other community
settings include: out-of-hours (OOH) services, walk-in centres, urgent & emergency care,
community health service, optometry services, hospices, care homes, nursing homes, and
custody [5]. Among these other community settings, the highest prescribing rate occurs in
OOH services, which account for 53.6% of prescribing within this category and 3.3% of
prescribing in primary care [6]. In England, OOH services run from 6.30 p.m. to 8.00 a.m.
on weekdays and all day on weekends and on bank holidays to provide treatment and
advice for patients whose medical issues are not life-threatening but urgent, when GP
surgeries are typically closed [7]. A range of antimicrobial stewardship, educational and
policy interventions have been implemented in England, aimed at improving the qual-
ity of antibiotic prescribing [8]. One such initiative, the antibiotic Quality Premium, a
financial incentive for local commissioners for targeted reductions in primary care antibi-
otic prescribing, was introduced in England in April 2015 with a focus on urinary tract
infection management and a reduction in co-amoxiclav and quinolones [9]. Antibiotic
consumption data shows that in-hour (IH) GPs have achieved a consistent reduction in
antibiotic prescribing since the introduction of the QPs, demonstrating a positive contribut-
ing impact of this initiative [10,11]. Despite the improvement in IH GP settings, little has
been achieved to improve antibiotic use in OOHs [5]. Existing evidence suggests that the
antibiotic prescribing volume is higher in OOH services than in IH GP practices for the
same patient population. Nationwide, the proportion of prescriptions of broad-spectrum
agents decreased in OOH and IH between 2010 and 2014; however, this proportion was
always higher in OOH compared with IH [12]. There are regional variations; for example,
a study in Oxfordshire shows a trend of an increased number of OOH antibiotic prescrip-
tions between 2010 and 2014 against a decreased number of consultations [13,14]. Limited
information is available to clarify whether GP prescribing has been displaced from in-hour
general practices to other settings including OOH services.
There is little research exploring OOH antibiotic prescribing and limited AMS inter-
ventions specifically tailored to this setting [15]. However, assessing antibiotic use in OOH
has become increasingly important given that the utilisation of OOH services has increased
year on year and in relation to hospital Acute & Emergency (A&E) centres since 2017 [16].
The ongoing acute viral pandemic caused by SARS-CoV-2 (COVID-19) has driven a rapid
reconfiguration of primary care provision in England. Patients were re-directed away from
acute hospital and OOHs healthcare facilities to reduce the infection transmission and ‘pro-
tect the NHS’; this was done either by healthcare triage or voluntarily by patients [17,18].
Lockdown and the need for social and physical distancing have led to an increase in remote
GP consultations. Data collected from more than 500 GP practices in England by the Royal
College of General Practice shows that during the first wave of the pandemic (April 2020),
around 71% of GP consultations were conducted remotely by telephone or video and
25% were conducted face to face. For the same period in 2019, 25% of consultations were
conducted remotely and 70% face to face [19,20]. Remote consultation is reported to have
increased clinical uncertainty in infection management without the benefit of an in-person
assessment and diagnostic tests IH and OOH [21]. This is in addition to the challenges
already faced by OOH GP staff (being unfamiliar with patients) and usually without access
to the patient’s complete medical history [22]. The OOH setting is also diverse in the range
of providers and types of contracts and teams involved. During the COVID-19 pandemic
prevaccination, OOH practices and their staff were used to support urgent care centres and
walk-in centres designated to provide face-to-face consultations for respiratory patients;
referred to as the ‘hot hubs’, these practices or medical centres acted as sites where patients
with coronavirus symptoms were seen face to face [17].
The aim of this study is to investigate any changes in OOH antibiotic use prior to and
during England’s first wave of the COVID-19 pandemic.
Antibiotics 2021, 10, 32 3 of 10
2. Results
2.1. Antibiotic Prescribing in GP In-Hours and Out-of-Hours
Antibiotic prescribing in OOH settings measured in terms of antibiotic items represented
3.3–3.6% of the total primary care antibiotic prescriptions from 2016 to 2019. (Table 1).
Table 1. Antibiotic items prescribed in different settings.
Year
Prescribed Antibiotic Items Prescribed Antibiotic Items per 1000 Inhabitants per day Proportion of Primary
Care Volume Prescribed in
OOH (%)Primary Care GP In-Hours GP Out-Of-Hours Primary Care GP In-Hours GP Out-Of-Hours
2016 34,881,080 32,844,420 1,178,023 1.7 1.6 0.1 3.4%
2017 33,654,010 31,558,849 1,163,962 1.7 1.6 0.1 3.5%
2018 32,362,944 30,159,393 1,177,075 1.6 1.5 0.1 3.6%
2019 31,714,925 29,429,925 1,136,791 1.5 1.4 0.1 3.6%
2020 1,2 14,855,823 13,933,878 492,244 1.5 1.3 0.1 3.3%
1. Only includes data from January to June 2020; 2. Mid-year population estimate of 2020 was not available when this study was conducted;
therefore, the 2019 estimate was used.
The prescription volume peaked each year in December for both IH and OOH GP
(Figure 1). Prior to the COVID-19 pandemic (from January 2016 to February 2020), IH
GP prescribing followed a downward trend; a decrease of 7329 items per month (95% CI:
−12,478.14 to −2179.61, p < 0.05). For the same period, there was no statistically significant
change in the number of items prescribed monthly in OOH (p = 0.42). Measured by the
number of items, penicillins remained the most commonly prescribed antibiotic group
(61.6%) by OOH GPs, followed by tetracyclines (11.2%) and macrolides (10.30%), which
were the same as for IH GPs. Each year, the proportion of broad-spectrum antibiotics
(cephalosporins, quinolones and co-amoxiclav) to the total prescription volume was the
highest in August, both among IH and OOH GPs.
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Figure 1. Total number of antibiotic items prescribed (England, 2016–2020).
The proportion of broad-spectrum antibiotics to total antibiotic prescribing in OOH
was consistently higher (10.1%, 95% CI: 10.0% to 10.2%, p < 0.05) compared with in-hours
(8.7%, 95% CI: 8.6% to 8.8%, p < 0.05) (Figure 2). Before March 2020, the proportion of
prescribed broad-spectru antibiotics decreasing by 0.02 per month in GP IH set ings
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(95% CI: −0.03% to −0.01%, p < 0.05). While a decrease of 0.02% per month was observed
in the proportion of prescribed broad-spectrum antibiotics in OOH, this is insignificant
(p = 0.06).
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Figure 2. Percentage of broad-spectrum antibiotics prescribed (England, 2016–2020).
2.2. Respiratory Tract and Chest Infection Antibiotics in Out-of-Hours
While the OOH prescribing of ciprofloxacin and cephalosporins remained stable
within each year, the prescribing of co-amoxiclav, amoxicillin and doxycycline peaked in
December every year, with the seasonality indicating a high use of amoxicillin in winter
to treat respiratory tract infections (Figure 3). In 2020, the OOH use of co-amoxiclav and
doxycycline peaked between March to May, which was out of sync with the seasonality
peaks (Winter) in previous years (Figure 3).
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2.3. Urinary Tract Infection Antibiotics in Out-of-Hours
Between 2016 and 2020, there has been a consistent reduction in trimethoprim pre-
scribing and the trimethoprim-to nitrofurantoin-ratio in OOH settings (Figure 4) from 1.9
in January 2016 to 0.3 in June 2020.
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2.4. Out-of-Hours Antibiotic Prescribing in the Context of the COVID-19 Pandemic
The trend of the OOH antibiotic prescribing volume between January 2016 and Febru-
ary 2020 remained stable. Since Marc 2020, there has been a decrease of 5088 items per
month (95% CI: −6264.4 to −3912.0). The predicted monthly OOH antibiotic prescribing
v l me is presented in Figure 5 to illustrate the variation from the historical trend that
would have been expected in the absence of the COVID-19 pandemic (Figure 5).
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Since March 2020, the proportion of broad-spectrum prescriptions rose in both settings.
In IH, the downward trend of the proportion of broad-spectrum prescribing switched
direction and started to rise from March, increasing by 0.7% per month (95% CI: 0.3% to
1.2%, p < 0.05). In OOHs, though the proportion of broad-spectrum antibiotic prescribing
showed no significant overall change prior to March 2020, it started increasing by 1.4% per
month (95% CI: 0.9% to 1.9%, p < 0.05) since.
3. Discussion
The introduction of national antimicrobial stewardship initiatives has reduced an-
tibiotic prescribing primary care in England. Despite the overall decline in primary care
antibiotic prescribing between January 2016 to February 2020, the prescribing volume in
OOH remained unchanged. The prescribing of broad-spectrum antibiotics in OOH has
been consistently higher than IH, as previously reported using data between 2010 and 2014
from 143 out of 221 Clinical Commissioning Groups (CCGs) in England [12]. The positive
impact of the QP that was aimed at increasing the use of nitrofurantoin as the first-line
treatment for uncomplicated UTI is evident [23], with a decrease of the trimethoprim-to-
nitrofurantoin ratio across primary care including OOH settings, though data for assessing
QP in OOH is incomplete. The COVID-19 pandemic and the national response have led to
a reduction in prescribing in both IH and OOH GPs since March 2020, which may tell us
more about patient health-seeking behaviour than clinician prescribing behaviours. The
proportion of broad-spectrum antibiotics from the total prescribed antibiotics has, however,
increased in both IH and OOH GPs. Co-amoxiclav and doxycycline use in OOH peaked
between March and May 2020, probably due to the uptake and implementation of National
Institute for Health and Care Excellence (NICE) prescribing guidelines advising doxycy-
cline for the management of community-acquired pneumonia when the cause was unclear
during the COVID-19 pandemic [24]. As a percentage of the total, co-amoxiclav may have
increased, as OOH clinicians prescribed broad-spectrum antibiotics more frequently to
cover a greater range of potential infections when they were unable to assess their patients
face to face.
We cannot rule out a changing epidemiological profile of infectious diseases due
to COVID-19 as a possible factor in the decline in OOH antibiotic prescribing, resulting
from control measures and a consequent reduced transmission of other respiratory tract
infections. Indeed, PHE’s OOH GP syndromic surveillance data indicates that although on
average 23% of all OOH GP contacts in England between 2009 and 2019 were due to acute
respiratory infection [25], OOH GP contacts for acute respiratory infections, including sore
throat, were lower than expected in 2020. During March to August 2020, the daily OOH
contacts due to acute respiratory infection fell to 40% of the baseline based on 10-year
historical data [25].
Our study has two limitations. The first limitation is associated with the quality of the
publicly available data. Not all of the prescribing centres in the NHS BSA prescribing data
can be identified in the NHS Digital classification of organisations. Therefore, we had to
exclude those prescribing records where the setting could not be assigned. This accounted
for 0.04% (10,649/23,975,061) of the total prescribing records. Second, our analysis did not
capture how OOH consultations were delivered, especially during COVID-19, when an
increase in remote consultations was observed in IH GPs [19,20]. Research in how remote
consultations might have influenced antibiotic prescribing in the community is urgently
needed [26].
Despite the limitations, this study provides the first critical insight into antibiotic
prescribing in OOH before and during the COVID-19 pandemic and provides the scope for
future research. The ongoing monitoring of consultations, antibiotic prescribing and AMR
resistance is required to detect any unintended consequences of the change in antibiotic
prescribing in OOHs seen in this study. For instance, the increase in co-amoxiclav use
in OOH might lead to a rise in the incidence of Clostridium difficile infections in the
community. In the current landscape, we also need to investigate OOH service provisions
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to better understand the factors influencing prescribing decision-making in OOH. As of
2013, the responsibility for commissioning OOH services in England was delegated to
CCGs, which are independent statutory bodies governed by GPs to buy services for the local
community from providers including hospitals, social enterprises, voluntary organisations
and private firms [27]. The contractual arrangements of OOH services are complex and
have undergone significant policy changes in recent years due to factors such as CCG
mergers, joint commissioning, and the integration of patient triage, ambulance dispatches
and OOH care provision [28]. The periodic change of OOH service providers, regional
use of paper-based prescriptions and unintegrated electronic patient record systems have
challenged the investigation of OOH antibiotic prescribing [12]. An in-depth analysis is
required to assess the variation in the OOH care accessibility and quality between different
types of service providers, and to evaluate the existing antimicrobial stewardship policies
used by them. Monitoring should continue during and beyond the COVID-19 pandemic to
determine the long-term impact of possible clinician prescribing behaviour changes versus
patient OOH consulting behaviour changes.
4. Materials and Methods
4.1. Ethical Approval
This study did not require ethical approval as it employed publicly available data.
4.2. Data
Out-of-hours antibiotic prescribing data: We extracted records of electronic-based
prescriptions of each prescribing centre in England between January 2016 and June 2020
from the NHS Business Service Authority (BSA) [29,30]. The prescribing data contains the
number of prescribed antibiotic items each month by prescribing centre. We used the NHS
Digital classification of organisations to identify the type of setting for each prescribing
centre [31]. Prescribing centres coded as “OOH” and “OOH + walk-in centres (WIC)” were
considered OOH practices. We included prescriptions in the British National Formulary
(BNF) Sub-chapter 5.1 (antibacterial drugs) [32].
Population data: We extracted the mid-year estimates of the population in each region
and CCG from the Office for National Statistics (ONS) for the years 2016 to 2019 [33].
4.3. Descriptive and Statistical Analysis
We report the trend in the OOH antibiotic prescribing volume in England from January
2016 to June 2020. Using the number of items as the measure of the prescribing volume,
the trend is compared with IH GP antibiotic prescribing. We examined key agents in the
antibiotic QP primary care component, including nitrofurantoin, trimethoprim, amoxicillin,
co-amoxiclav (amoxicillin and clavulanic acid), ciprofloxacin and cephalosporins [34]. In
addition, we also assessed the prescribing volume of doxycycline, which is an antibiotic
agent recommended for the management of suspected or confirmed pneumonia in adults
in the community during COVID-19 [24]. The percentage of broad-spectrum to total
antibiotic prescriptions per month during IHs and OOHs was compared using a linear
regression. To determine whether there was a measurable change in the underlying
trend of the OOH antibiotic prescribing volume before and after the national COVID-
19 response was imposed in England on 26 March 2020, we performed an interrupted
time series analysis (ITSA). ITSA is a quasi-experimental research design commonly used
for the evaluation of longitudinal effects of interventions or incidents that might affect
population-level health outcomes [35]. ITSA is particularly useful for assessing outcomes
before and after an intervention is introduced when it is not possible or ethical to conduct
clinical trials [35]. In this study, we define the intervention as the combination of (a) the
national lockdown limiting public movement, (b) the local reconfiguration of primary
care provisions including walk-in centre closure or the referral of cases to respiratory hot
hubs, and (c) the switch to telephone- and video-based consultations in place of face-to-
face interactions. The date of the national lockdown (26 March 2020) was used as the
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implementation date of the “intervention” [36]. We constructed monthly time series of
the number of antibiotic items prescribed in OOH settings for the period from January
2016 to June 2020. We performed ITSA to produce Newey—West standard errors for
coefficients estimated by ordinary least squared (OLS) regression, which assumed that the
errors followed a first-order autoregressive process [37]. We adjusted for seasonality by
including each calendar month as an independent variable in the model [36].
All descriptive and statistical analyses were performed in STATA 15 (StataCorp, TX, USA).
5. Conclusions
This study has provided an insight into the impact of COVID-19 on antibiotic pre-
scribing in OOH settings in the UK. Further investigation is required to see whether the
observed reduction in OOH antibiotic prescribing persists and how this reduction might
influence AMR and patient outcomes. Monitoring OOH prescribing requires the same
primacy as IH prescribing in order to develop antimicrobial stewardship programmes with
relevant underpinning evidence. This is all the more important since, in particular, the
boundaries between IH and OOH may have different meanings for the healthcare user in
the current and continuing context of COVID-19.
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